Tannous Zeina S, Mihm Martin C, Sober Arthur J, Duncan Lyn M
Dermatopathology Unit, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
J Am Acad Dermatol. 2005 Feb;52(2):197-203. doi: 10.1016/j.jaad.2004.07.020.
Congenital melanocytic nevi occur in approximately 1% of newborns and are usually classified according to their size. Giant congenital melanocytic nevi are most simply defined as melanocytic nevi that are greater than 20 cm in largest dimension; whereas small congenital nevi are defined as melanocytic nevi less that 1.5 cm in largest dimension. Congenital nevi can exhibit distinctive histologic features that can help in differentiating them from common acquired nevi. Giant congenital melanocytic nevi are associated with an increased risk of the development of melanoma. On the other hand, there is evidence of an increased melanoma risk in patients with small congenital nevi. Nevertheless, the risk of malignant transformation in small congenital nevi and the lifetime melanoma risk in patients with small congenital nevi remain controversial. In large part due to inconsistency in the reported literature describing patients with congenital melanocytic nevi, the risk of melanoma in these patients remains unclear and consistent guidelines for clinical management do not exist. We review the literature and comment on the course of management for these patients at the Massachusetts General Hospital Pigmented Lesion Clinic.
先天性黑素细胞痣约在1%的新生儿中出现,通常根据其大小进行分类。巨大先天性黑素细胞痣最简单的定义是最大直径大于20厘米的黑素细胞痣;而小先天性痣则定义为最大直径小于1.5厘米的黑素细胞痣。先天性痣可表现出独特的组织学特征,有助于将它们与常见的后天性痣区分开来。巨大先天性黑素细胞痣与黑色素瘤发生风险增加相关。另一方面,有证据表明小先天性痣患者患黑色素瘤的风险增加。然而,小先天性痣的恶性转化风险以及小先天性痣患者的终生黑色素瘤风险仍存在争议。很大程度上由于报道先天性黑素细胞痣患者的文献存在不一致性,这些患者患黑色素瘤的风险仍不明确,且不存在统一的临床管理指南。我们回顾了相关文献,并对麻省总医院色素沉着病变诊所这些患者的治疗过程进行了评论。